Spiraeoside, ROTICHROM® CHR, 10 mg, conditionnement verre

(3-Chloro-5-(methoxycarbonyl)phenyl)boronic acid, 95.0%, 1g

5-oxo-5-(3-oxopiperazin-1-yl)pentanoic acid, 98.0%, 5g

(S)-1-tert-Butyl 4-methyl 2-aminosuccinate hydrochloride, 95.0%, 5g

4-(2-Chlorophenyl)-4-oxobutyric acid, 95.0%, 250mg

4'-Fluoro-3'-(trifluoromethyl)acetophenone, 98.0%, 500g

1,3-Divinyltetramethyldisilazane, >95%, 100g

2-Bromo-5-fluoro-4-methylbenzaldehyde, 95.0%, 10g

3-Nitrobenzenesulfonic Acid>98.0%(HPLC)(T)5g

4,4,5,5-Tetramethyl-2-(3-perylenyl)-1,3,2-dioxaborolane>97.0%(GC)1g

1H,3H-Naphtho[1,8-cd]pyran-6-sulfonic acid, 1,3-dioxo-, potassium salt, 97%, 5g

2-(4-((Trifluoromethyl)thio)phenyl)acetonitrile, 95.0%, 5g

Colonne capillaire GC ROTI®Cap-5, 15 m, 0,53 mm, 1,00 µm, 1 pièce(s)